GH RESEARCH PLC (GHRS)

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +0.14%, and the average quarterly price growth was +5.81%. GH is expected to report earnings on Jul 30, 2026. GHRS is expected to report earnings .…

Looking to buy GH Research PLC Stock? Get the latest GHRS quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

GH Research PLC (NASDAQ:GHRS) is one of the 10 Stocks That Have the Potential to Rise 1000%. On May 19, 2026, H.C. Wainwright lowered the firm’s price target on GH Research PLC (NASDAQ:GHRS) to $65 from $70 and maintained a Buy rating on the shares. H.C. Wainwright cited share count dilution ...

GH Research (NasdaqGM:GHRS) has drawn fresh attention after publishing Phase 2b results for its lead depression treatment in JAMA Psychiatry, advancing Phase 1 programs and outlining a global Phase 3 plan, while reporting a sizeable cash position. See our latest analysis for GH Research.

GH Research PLC reported a wider quarterly loss as the clinical-stage biopharmaceutical company continues investing in its depression treatment pipeline.